Literature DB >> 24911418

Circulating microRNA expression profiles in ovarian cancer.

L Ayaz1, F Çayan, Ş Balci, A Görür, S Akbayir, H Yıldırım Yaroğlu, N Doğruer Unal, L Tamer.   

Abstract

MicroRNA (miRNA) is an abundant class of small non-coding RNAs that act as gene regulators. Recent studies have suggested that miRNA deregulation is associated with the initiation and progression of human cancer. However, information about ovarian cancer-related miRNA is mostly limited to tissue miRNA. The aim of this study was to find specific profiles of plasma-derived miRNAs of ovarian cancer. In this present study, the expression profiles of 740 miRNAs in plasma from 18 patients and 24 healthy women subjects were evaluated using microfluidic based multiplex qRT-PCR. Our results demonstrated that expression levels of eight miRNAs were significantly upregulated in patients with ovarian cancer when compared with a control group (p < 0.05). Expression levels of four miRNAs were found significantly downregulated in patients with ovarian cancer (p < 0.05). In addition, 10 miRNAs were expressed only in the ovarian cancer group and miR-138-5p of these miRNAs is ovarian specific. In conclusion, our study suggests that detecting these ovarian cancer specific miRNAs in plasma might serve as novel non-invasive biomarkers for ovarian cancer.

Entities:  

Keywords:  MicroRNA; RT-PCR; miRNA; ovarian cancer; plasma miRNA

Mesh:

Substances:

Year:  2014        PMID: 24911418     DOI: 10.3109/01443615.2014.919998

Source DB:  PubMed          Journal:  J Obstet Gynaecol        ISSN: 0144-3615            Impact factor:   1.246


  11 in total

Review 1.  Emerging diagnostic, prognostic and therapeutic biomarkers for ovarian cancer.

Authors:  Khalid El Bairi; Abdul Hafeez Kandhro; Adel Gouri; Wafaa Mahfoud; Noureddine Louanjli; Brahim Saadani; Said Afqir; Mariam Amrani
Journal:  Cell Oncol (Dordr)       Date:  2016-12-15       Impact factor: 6.730

Review 2.  Circular RNA participates in the carcinogenesis and the malignant behavior of cancer.

Authors:  Zhen-Jun Zhao; Jun Shen
Journal:  RNA Biol       Date:  2015-12-09       Impact factor: 4.652

3.  MicroRNA profiling of ovarian granulosa cell tumours reveals novel diagnostic and prognostic markers.

Authors:  Andrew N Shelling; Cherie Blenkiron; Wei-Tzu Cheng; Roseanne Rosario; Anita Muthukaruppan; Michelle K Wilson; Kathryn Payne; Peter C Fong
Journal:  Clin Epigenetics       Date:  2017-07-21       Impact factor: 6.551

4.  Maternal plasma miRNAs as biomarkers during mid-pregnancy to predict later spontaneous preterm birth: a pilot study.

Authors:  Clint Gray; Lesley M McCowan; Rachna Patel; Rennae S Taylor; Mark H Vickers
Journal:  Sci Rep       Date:  2017-04-11       Impact factor: 4.379

5.  CircDOCK1 suppresses cell apoptosis via inhibition of miR‑196a‑5p by targeting BIRC3 in OSCC.

Authors:  Liping Wang; Yongxiang Wei; Yongyong Yan; Haiyan Wang; Jiantin Yang; Zhichao Zheng; Jun Zha; Peng Bo; Yinghua Tang; Xueqi Guo; Weihong Chen; Xinxin Zhu; Linhu Ge
Journal:  Oncol Rep       Date:  2017-12-28       Impact factor: 3.906

6.  Five serum microRNAs for detection and predicting of ovarian cancer.

Authors:  Weiwei Wang; Li-Rong Wu; Chunyu Li; Xin Zhou; Ping Liu; Xuemei Jia; Yan Chen; Wei Zhu
Journal:  Eur J Obstet Gynecol Reprod Biol X       Date:  2019-04-06

7.  Knockdown of long non-coding RNA HOTAIR reverses cisplatin resistance of ovarian cancer cells through inhibiting miR-138-5p-regulated EZH2 and SIRT1.

Authors:  Yun Zhang; Hao Ai; Xue Fan; Suxian Chen; Yadi Wang; Lili Liu
Journal:  Biol Res       Date:  2020-04-29       Impact factor: 5.612

Review 8.  Role of microRNAs as Clinical Cancer Biomarkers for Ovarian Cancer: A Short Overview.

Authors:  Cristina Elena Staicu; Dragoș-Valentin Predescu; Călin Mircea Rusu; Beatrice Mihaela Radu; Dragos Cretoiu; Nicolae Suciu; Sanda Maria Crețoiu; Silviu-Cristian Voinea
Journal:  Cells       Date:  2020-01-09       Impact factor: 6.600

9.  Plasma microRNA expression profiles in Chinese patients with rheumatoid arthritis.

Authors:  Wenhong Wang; Yingying Zhang; Bo Zhu; Tanghai Duan; Qiugui Xu; Rui Wang; Liwei Lu; Zhijun Jiao
Journal:  Oncotarget       Date:  2015-12-15

Review 10.  Clinical relevance of circulating cell-free microRNAs in ovarian cancer.

Authors:  Koji Nakamura; Kenjiro Sawada; Akihiko Yoshimura; Yasuto Kinose; Erika Nakatsuka; Tadashi Kimura
Journal:  Mol Cancer       Date:  2016-06-24       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.